Alemtuzumab

Common brands: Lemtrada, Campath, Fludarabine, Methylprednisolone Sodium Succinate, Cellcept

Top reporter: Genzyme Corporation

CD52-directed Cytolytic Antibody [EPC]Corticosteroid [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Alkylating Drug [EPC]Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
19,103
Total Reports
6,467
Serious Reports
2,899
Death Reports
30
Reported Reactions
Death Report Ratio: High (15.18%)

Patient Demographics

Male
6,345
Female
9,071

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Alemtuzumab.

# Reaction Reports % of Total
1 HEADACHE 1,892
7.0%
2 FATIGUE 1,864
6.9%
3 PYREXIA 1,770
6.6%
4 OFF LABEL USE 1,626
6.0%
5 RASH 1,190
4.4%
6 NAUSEA 1,181
4.4%
7 DRUG INEFFECTIVE 1,013
3.8%
8 DYSPNOEA 983
3.7%
9 ASTHENIA 938
3.5%
10 MULTIPLE SCLEROSIS RELAPSE 907
3.4%
11 LYMPHOCYTE COUNT DECREASED 876
3.3%
12 CYTOMEGALOVIRUS INFECTION 840
3.1%
13 URINARY TRACT INFECTION 815
3.0%
14 PAIN 752
2.8%
15 CONDITION AGGRAVATED 718
2.7%
16 PLATELET COUNT DECREASED 708
2.6%
17 COUGH 679
2.5%
18 DIZZINESS 656
2.4%
19 WHITE BLOOD CELL COUNT DECREASED 656
2.4%
20 DIARRHOEA 655
2.4%
21 VOMITING 655
2.4%
22 MALAISE 651
2.4%
23 GAIT DISTURBANCE 650
2.4%
24 NEUTROPENIA 644
2.4%
25 PNEUMONIA 640
2.4%
26 MUSCULAR WEAKNESS 609
2.3%
27 PRURITUS 600
2.2%
28 THROMBOCYTOPENIA 598
2.2%
29 INSOMNIA 587
2.2%
30 PRODUCT USE IN UNAPPROVED INDICATION 577
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.